Jade Biosciences

Jade Biosciences Inc. is a clinical-stage biotechnology company headquartered in Waltham, Massachusetts, focused on developing transformative therapies to redefine the standard of care for patients living with autoimmune diseases. The company is dedicated to developing innovative, best-in-class therapies to address critical unmet needs in inflammat... ion and immunology indications. Jade Biosciences was launched based on assets licensed from Paragon Therapeutics, an antibody discovery engine, and is the fourth company founded based on assets generated by Paragon. The company is advancing a portfolio of novel therapies that aim to transform the standard of care for patients with autoimmune diseases, with a pipeline that includes multiple development candidates and antibody discovery programs in various stages of clinical and preclinical development. Jade Biosciences operates with a focus on developing targeted therapies for indications with high unmet need across inflammation and immunology. The company leverages cutting-edge science and technology to identify and propel potentially best-in-class biologics into clinical development. Jade Biosciences is committed to rapidly discovering and developing novel treatments for patients and continues the legacy of innovation established by Paragon Therapeutics in creating companies dedicated to addressing serious medical conditions.Read More